No description
-
2021 (v1)PublicationUploaded on: April 14, 2023
-
2022 (v1)Publication
In recent years, the inhibition of beta-amyloid (A beta) aggregation has emerged as a potential strategy for Alzheimer's disease. KLVFF, a small peptide corresponding to the aminoacidic sequence 16-20 of A beta, reduces A beta fibrillation dose dependently. Therefore, the toxic and functional characterization of its brain activity is...
Uploaded on: February 14, 2024 -
2022 (v1)Publication
No description
Uploaded on: February 13, 2024 -
2022 (v1)Publication
No description
Uploaded on: February 14, 2024 -
2022 (v1)Publication
No description
Uploaded on: February 14, 2024 -
2018 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2018 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2018 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2019 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2017 (v1)Publication
No description
Uploaded on: April 14, 2023